Taro sees more price led growth in US in FY15: Taro reported FY15 total sales of $863 million, of which the US contributed $777 million. US sales... ...http://www.financialexpress.com/article/markets/indian-markets/buy-sun-pharma-after-sustained-earnings-by-taro/94494/
" Sun Pharma is the stock, as a disclosure we do have a positive coverage. From current level, the downside is protected. Merger of Ranbaxy with... ...http://www.moneycontrol.com/news/stocks-views/investsun-pharma-target-rs-1050-gaurang-shah_1779281.html
FabFurnish co-founders Vikram Chopra and Mehul Agrawal have stepped down from daily responsibilities and will be replaced by senior directors... ...http://www.medianama.com/2015/07/223-fabfurnish-vikram-chopra-mehul-agrawal-step-down-continue-as-advisors/
Eight therapies have outgrown the IPM growth The Indian pharma market (IPM) clocked Rs 7717 crores in May 2015. The market grows at 11 per cent... ...http://www.financialexpress.com/article/pharma/market-pharma/indian-pharma-market-clocks-rs-7717-crores-in-may-2015/94137/
MUMBAI: India Inc is staring at yet another quarter of dismal financial performance but a turnaround may not be far away according to estimates by... ...http://economictimes.indiatimes.com/markets/stocks/earnings/india-inc-to-see-muted-earnings-for-one-more-quarter-but-worst-is-over/articleshow/47919221.cms
working in Ranbaxy
fadsf fdsfasdcv asdsf vasddfasd
The pain reliever brand has launched...
The company was formed way back in...